Readiness before
ambition.

Every year, growth companies across China, Hong Kong, Singapore, Taiwan, and wider Asia are pitched a six-figure Nasdaq dream. Engagement letters are signed, retainers are paid, and only then does someone discover the audit will not survive PCAOB scrutiny, the float math does not work, or a cross-border filing was never mapped. The money is gone before the first real question is answered.

We invert the sequence. Assessment comes first. Before any budget is committed, we examine the company's structure, financials, shareholder base, and disclosure position, and we say plainly whether a U.S. OTC market path — OTCQB, OTCQX, or neither — is realistic. Sometimes the honest answer is "not yet." Sometimes it is "not this route at all." An honest no at the start is worth more than an expensive maybe at the end.

What we do. Readiness assessment, diligence, documentation, and coordination: we identify blockers, prepare the evidence package that licensed professionals will require, and make introductions and referrals to the auditors, counsel, transfer agents, and market makers who execute the regulated work.

What we deliberately do not do. We do not underwrite. We do not effect securities transactions. We do not give legal opinions. We do not perform audits. We do not promote or tout any stock. Those activities belong to licensed parties acting under their own licenses — and we keep that line bright on purpose.

OTC IPO Expert was built by capital-markets practitioners with U.S. regulatory and cross-border experience — people who have sat on the professional side of listings, quotations, and the diligence that precedes them, and who have watched too many issuers pay for the wrong path.

We work bilingually in English and Simplified Chinese, and we keep the platform independent: no underwriting economics, no securities business, no incentive to steer a company toward a market it is not ready for. Client identities are never published, and case details stay confidential.